TLRY - Tilray Brands, Inc.

7.21
0.150   2.080%

Share volume: 2,678,441
Last Updated: 03-06-2026
Pharmaceutical Products/Medicinal Chemicals: 2.29%

PREVIOUS CLOSE
CHG
CHG%
$7.06
0.15
0.02%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
55%
Profitability 50%
Dept financing 36%
Liquidity 31%
Performance 70%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-5.13%
1 Month
-6.36%
3 Months
0.14%
6 Months
543.75%
1 Year
939.35%
2 Year
804.19%
Key data
Stock price
$7.21
P/E Ratio 
0.00
DAY RANGE
$6.86 - $7.30
EPS 
-$2.73
52 WEEK RANGE
$0.35 - $15.70
52 WEEK CHANGE
$1,008.21
MARKET CAP 
912.888 M
YIELD 
N/A
SHARES OUTSTANDING 
116.507 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
07-28-2025
BETA 
0.00
PUBLIC FLOAT 
N/A
AVERAGE 10 VOLUME 
$2,744,424
AVERAGE 30 VOLUME 
$2,725,491
Company detail
CEO: Irwin D. Simon
Region: US
Website: tilray.com
Employees: 1,700
IPO year: 2018
Issue type:
Market: XNAS
Industry: Pharmaceutical Products/Medicinal Chemicals
Sector: Manufacturing

Tilray Brands Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products. It operates through five segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, Wellness Business, and Business Under Development. The company operates Tilray Medical, which provides GMP-certified flowers, oils, vapes, edibles, and topicals.

Recent news